Anti-STX18 monoclonal antibody

Pre-made anti-STX18 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to STX18/STX18 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1850-Ab-1/ GM-Tg-hg-IP1850-Ab-2Anti-Human STX18 monoclonal antibodyHuman
GM-Tg-rg-IP1850-Ab-1/ GM-Tg-rg-IP1850-Ab-2Anti-Rat STX18 monoclonal antibodyRat
GM-Tg-mg-IP1850-Ab-1/ GM-Tg-mg-IP1850-Ab-2Anti-Mouse STX18 monoclonal antibodyMouse
GM-Tg-cynog-IP1850-Ab-1/ GM-Tg-cynog-IP1850-Ab-2Anti-Cynomolgus/ Rhesus macaque STX18 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1850-Ab-1/ GM-Tg-felg-IP1850-Ab-2Anti-Feline STX18 monoclonal antibodyFeline
GM-Tg-cang-IP1850-Ab-1/ GM-Tg-cang-IP1850-Ab-2Anti-Canine STX18 monoclonal antibodyCanine
GM-Tg-bovg-IP1850-Ab-1/ GM-Tg-bovg-IP1850-Ab-2Anti-Bovine STX18 monoclonal antibodyBovine
GM-Tg-equg-IP1850-Ab-1/ GM-Tg-equg-IP1850-Ab-2Anti-Equine STX18 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1850-Ab-1/ GM-Tg-hg-IP1850-Ab-2; GM-Tg-rg-IP1850-Ab-1/ GM-Tg-rg-IP1850-Ab-2;
GM-Tg-mg-IP1850-Ab-1/ GM-Tg-mg-IP1850-Ab-2; GM-Tg-cynog-IP1850-Ab-1/ GM-Tg-cynog-IP1850-Ab-2;
GM-Tg-felg-IP1850-Ab-1/ GM-Tg-felg-IP1850-Ab-2; GM-Tg-cang-IP1850-Ab-1/ GM-Tg-cang-IP1850-Ab-2;
GM-Tg-bovg-IP1850-Ab-1/ GM-Tg-bovg-IP1850-Ab-2; GM-Tg-equg-IP1850-Ab-1/ GM-Tg-equg-IP1850-Ab-2
Products NameAnti-STX18 monoclonal antibody
Formatmab
Target NameSTX18
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-STX18 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1850-Ag-1Recombinant multi-species STX18/ Ufe1 protein


    Target information

    Target IDGM-IP1850
    Target NameSTX18
    Gene ID53407,71116,360953,712216,609342,101088331,614135,100056340
    Gene Symbol and Synonyms1810035L21Rik,4933425D03Rik,STX18,Ufe1
    Uniprot AccessionQ9P2W9,Q68FW4
    Uniprot Entry NameSTX18_HUMAN,STX18_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000168818
    Target ClassificationN/A

    The target: STX18, gene name: STX18, also named as Ufe1. This gene encodes a member of the syntaxin family of soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) which is part of a membrane tethering complex that includes other SNAREs and several peripheral membrane proteins, and is involved in vesicular transport between the endoplasmic reticulum (ER) and the Golgi complex. The encoded protein is important for the organization of the smooth, rough, and exit site ER subdomains. A pseudogene of this gene has been identified. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.